Received Feb 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPHEPBIP | DTAP + HEPB + IPV (PEDIARIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | X9EP5 | IM / LL |
Patient administered vaccine in clinic and returned to clinic 2 days later with concerns for potential vaccine reaction. Assessment was done by PCP in which redness and swelling was noted near site of vaccine administration. Patients' family was educated on additional signs and symptoms to watch for and additional fact finding and vaccine education was completed with staff at the clinic.